We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLS icon
326
Celestica
CLS
$39.8B
$401K 0.01%
1,100
– –
CNC icon
327
Centene
CNC
$33.5B
$398K 0.01%
6,206
-4,220
-40% -$226K
SO icon
328
Southern Company
SO
$102B
$398K 0.01%
4,159
+80
+2% +$7.53K
ACAD icon
329
Acadia Pharmaceuticals
ACAD
$4.83B
$393K 0.01%
15,546
-7,291
-32% -$160K
CRL icon
330
Charles River Laboratories
CRL
$13.7B
$393K 0.01%
1,734
-272
-14% -$48.4K
DGX icon
331
Quest Diagnostics
DGX
$26.2B
$391K 0.01%
1,843
-115
-6% -$22.6K
LH icon
332
Labcorp
LH
$26.6B
$385K 0.01%
1,376
-61
-4% -$16K
VTRS icon
333
Viatris
VTRS
$19.3B
$384K 0.01%
24,166
-3,379
-12% -$52.4K
EQIX icon
334
Equinix
EQIX
$103B
$384K 0.01%
368
+3
+0.8% +$3.21K
AGI icon
335
Alamos Gold
AGI
$15.6B
$382K 0.01%
12,604
-2,713
-18% -$110K
NTLA icon
336
Intellia Therapeutics
NTLA
$1.8B
$381K 0.01%
22,501
-2,609
-10% -$36.5K
GRAL
337
GRAIL Inc
GRAL
$3.59B
$380K 0.01%
5,573
-1,394
-20% -$82.1K
ZTS icon
338
Zoetis
ZTS
$31B
$380K 0.01%
5,283
+1,095
+26% +$103K
GEN icon
339
Gen Digital
GEN
$18.3B
$378K 0.01%
15,178
-35
-0.2% -$782
BCRX icon
340
BioCryst Pharmaceuticals
BCRX
$2.57B
$375K 0.01%
37,452
-7,080
-16% -$64K
BNY
341
Bank of New York Mellon
BNY
$112B
$374K 0.01%
2,587
-54
-2% -$7.38K
RVTY icon
342
Revvity
RVTY
$14.6B
$374K 0.01%
3,357
-535
-14% -$51.5K
PNC icon
343
PNC Financial Services
PNC
$97.9B
$373K 0.01%
1,514
+23
+2% +$5.15K
STE icon
344
Steris
STE
$21.9B
$372K 0.01%
1,766
+3
+0.2% +$643
CMI icon
345
Cummins
CMI
$76.7B
$370K 0.01%
519
-550
-51% -$362K
DUK icon
346
Duke Energy
DUK
$94.6B
$368K 0.01%
2,910
-2,213
-43% -$279K
CPNG icon
347
Coupang
CPNG
$27.5B
$368K 0.01%
+21,185
New +$382K
CPRX
348
DELISTED
Catalyst Pharmaceutical
CPRX
$367K 0.01%
11,669
-3,508
-23% -$104K
DVA icon
349
DaVita
DVA
$11.6B
$364K 0.01%
1,638
-498
-23% -$90.5K
PTC icon
350
PTC
PTC
$15.3B
$363K 0.01%
3,193
-60
-2% -$8.1K
12 13
14
15 16

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.